EB Pharma Developments

Alken ·KBO/BCE: BE 0780.755.671

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	31.3%	47.1%	better than 34% of 43 sector peers
Net result	€-1k	€27k	better than 23% of 43 sector peers
Equity	€5k	€92k	better than 16% of 43 sector peers
Gross operating margin	€-1k	€64k	better than 15% of 43 sector peers
Total assets	€17k	€226k	better than 5% of 43 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€17k
Current assets	29/58	€17k
Amounts receivable within one year	40/41	€8k
Cash & bank	54/58	€9k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€17k
Equity	10/15	€5k
Contributions / capital	10/11	€2k
Reserves	13	€4k
Accumulated profits (losses)	14	€0
Amounts payable	17/49	€12k
Amounts payable within one year	42/48	€12k
Trade debts payable within one year	44	€636
Income statement
Gross operating margin	9900	€-1k
Operating result	9901	€-2k
Financial income	75	€364
Financial charges	65	€123
Result before taxes	9903	€-1k
Net result for the period	9904	€-1k
Result to be appropriated	9905	€-1k

Summary